Denmark's Genmab has decided not to continue the development of a drug for cancer, acasunlimab, which had reached phase 3 testing, after a review of its medicines pipeline. The decision to end the ...
Editors Note: Deadline went through its normal editorial process in the newsgathering for this story. After a review in light of new information regarding the actors involved, the story has been ...
Cannabidiol (CBD) capsules are easy to use and can provide more consistent dosing than oils because each dose is premeasured. However, unlike CBD oils, CBD capsules are subject to the first-pass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results